TFC Financial Management Inc. Sells 23 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

TFC Financial Management Inc. reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 656 shares of the healthcare conglomerate’s stock after selling 23 shares during the quarter. TFC Financial Management Inc.’s holdings in UnitedHealth Group were worth $332,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in UNH. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the third quarter worth $37,000. Friedenthal Financial bought a new stake in UnitedHealth Group during the third quarter worth $51,000. DecisionPoint Financial LLC grew its holdings in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares in the last quarter. Finally, Highline Wealth Partners LLC bought a new stake in UnitedHealth Group during the third quarter worth $55,000. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $527.31 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $485.27 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The business’s 50-day moving average price is $526.25 and its 200-day moving average price is $563.96. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have weighed in on UNH. Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Finally, Bank of America dropped their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.